Wanbury Ltd
Wanbury Ltd (WANBURY) last traded at ₹264, a market capitalisation of ₹923 crore, on a P/E of 21.5. Over the past 52 weeks the stock has ranged between ₹162 and ₹360. Wanbury Ltd last reported results for the quarter ended Jun 2025, with sales of ₹163 crore and net profit of ₹13 crore. Figures are as of 25 Aug 2026 and are not real time.
Wanbury Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Wanbury Ltd quarterly results
In the quarter ended Jun 2025, sales were ₹163 cr, up 24.4% from ₹131 cr a year earlier. Net profit was ₹13 cr, up 1200.0% year on year.
| ₹ crore | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 144 | 146 | 139 | 131 | 161 | 133 | 172 | 163 |
| Expenses | 127 | 124 | 121 | 120 | 141 | 120 | 142 | 139 |
| Operating profit | 17 | 21 | 18 | 11 | 20 | 14 | 30 | 24 |
| OPM % | 12% | 15% | 13% | 8% | 12% | 10% | 17% | 15% |
| Other income | 1 | 1 | 26 | 1 | 2 | 1 | 2 | 0 |
| Interest | 8 | 8 | 7 | 8 | 10 | 10 | 9 | 8 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| Profit before tax | 7 | 10 | 34 | 1 | 8 | 1 | 19 | 14 |
| Tax % | -2% | -0% | 1% | 0% | 2% | 5% | -6% | 1% |
| Net profit | 7 | 10 | 34 | 1 | 8 | 1 | 20 | 13 |
| EPS (₹) | 2.25 | 3.14 | 10.27 | 0.32 | 2.45 | 0.37 | 6.18 | 4.10 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Wanbury Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 367 | 392 | 511 | 485 | 557 | 600 | 630 |
| Operating profit | 23 | 18 | 36 | 26 | 73 | 80 | 88 |
| OPM % | 6% | 4.7% | 7% | 5% | 13% | 13% | 14% |
| Net profit | 64 | -13 | 81 | -10 | 56 | 31 | 43 |
| EPS (₹) | 25.79 | -5.04 | 24.94 | -3.18 | 17.09 | 9.32 | 13.10 |
TTM is the trailing twelve months to the most recent quarter.
Wanbury Ltd growth and returns
- 10 Years
- 9%
- 5 Years
- 10%
- 3 Years
- 5%
- TTM
- 12%
- 10 Years
- 26%
- 5 Years
- 31%
- 3 Years
- 80%
- TTM
- 60%
- 10 Years
- 20%
- 5 Years
- 26%
- 3 Years
- 73%
- 1 Year
- -8%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- 77%
Wanbury Ltd shareholding pattern
Promoters held 43.01% at Jun 2026, up from 39.63% at Jun 2025. FIIs 0.89% and DIIs 0.06%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 39.77% | 39.76% | 39.76% | 39.63% | 43.09% | 43.08% | 43.01% | 43.01% |
| FIIs | 1.02% | 0.84% | 1.55% | 1.59% | 0.82% | 0.72% | 0.59% | 0.89% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.06% |
| Public | 59.21% | 59.40% | 58.68% | 58.79% | 56.08% | 56.21% | 56.39% | 56.04% |
| No. of shareholders | 17,199 | 17,999 | 17,889 | 17,894 | 17,717 | 17,261 | 16,732 | 17,174 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Wanbury Ltd corporate filings
- Press Release regarding EDQM approval for new product Rivaroxaban API, USFDA DMF Clearances.Company Updatemedium impact
Cruxal's analysis: Wanbury Ltd has secured European Directorate for the Quality of Medicines (EDQM) approval…
Read the full analysis - Press Release on Un-audited Financial Results for the quarter ended 30th June, 2026Company Updatemedium impact
Cruxal's analysis: Wanbury Limited reported Q1 FY27 revenue of 165.6 crore, a modest 1.5% YoY growth, while…
Read the full analysis - Outcome of the Board Meeting held on August 11, 2026Board Meetinghigh impact
Cruxal's analysis: Wanbury Limited reported Q1 FY27 revenue of 165.58 crore, showing a modest YoY increase…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Wanbury Ltd
Cruxal reads every Wanbury Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.